Expert Ratings for HealthEquity
Within the last quarter, HealthEquity (NASDAQ:HQY) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…
RBC Capital Maintains Outperform on HealthEquity, Raises Price Target to $75
RBC Capital analyst Sean Dodge maintains HealthEquity (NASDAQ:HQY) with a Outperform and raises the price target from $70 to $75.
Wells Fargo Maintains Overweight on HealthEquity, Raises Price Target to $104
Wells Fargo analyst Stan Berenshteyn maintains HealthEquity (NASDAQ:HQY) with a Overweight and raises the price target from $100 to $104.
Analyst Ratings for HealthEquity
Analysts have provided the following ratings for HealthEquity (NASDAQ:HQY) within the last quarter:
Goldman Sachs Upgrades HealthEquity to Neutral, Raises Price Target to $77
Goldman Sachs analyst Cindy Motz upgrades HealthEquity (NASDAQ:HQY) from Sell to Neutral and raises the price target from $64 to $77.
Analyst Ratings for HealthEquity
Within the last quarter, HealthEquity (NASDAQ:HQY) has observed the following analyst ratings:
Deutsche Bank Maintains Buy on HealthEquity, Raises Price Target to $68
Deutsche Bank analyst George Hill maintains HealthEquity (NASDAQ:HQY) with a Buy and raises the price target from $67 to $68.
HealthEquity Q2 EPS $0.33, Inline, Sales $206.10M Beat $203.82M Estimate
HealthEquity (NASDAQ:HQY) reported quarterly earnings of $0.33 per share which met the analyst consensus estimate. This is a 17.5 percent decrease over earnings of $0.40 per share from the same period last year. The
Earnings Scheduled For September 6, 2022
Companies Reporting Before The Bell
• LightInTheBox Holding (NYSE:LITB) is expected to report earnings for its second quarter.